InsiderClue
← All stocks

Nuvation Bio Inc.

NUVB Net selling
CIK 0001811063 #1916 in the set updated 18 Sep 2026
Bought (120 mo)
$24.46M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$76.26M
$0.00 on a plan · $9.73M straight out of an exercise
Sold at will
$66.53M
11 of 29 sales
Net
−$51.80M
−$42.07M against sales at will

By person

24 insiders · 71 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Omega Fund V, L.P. entity
10% owner
—
$64.30M (8)
−$64.30M
48,669,713
$345.19M
+1.8%
NODELMAN OLEG
Director
$14.78M (13)
$2.07M (2)
+$12.71M
31,751,919
$225.20M
+151.4%
EcoR1 Panacea Holdings, LLC entity
Director
$3.90M (1)
—
+$3.90M
390,000
$2.77M
—
Hattersley Gary
CHIEF SCIENTIFIC OFFICER
—
$3.88M (4) scheduled
−$3.88M
0
$0.00
—
Cui Xiangmin
Director
$2.32M (4)
—
+$2.32M
17,062,202
$121.01M
—
Liu Dongfang
CHIEF MEDICAL OFFICER
—
$1.92M (8) scheduled
−$1.92M
18,000
$127.66K
0.0%
Hung David
PRESIDENT AND CEO
$1.71M (3)
—
+$1.71M
59,281,054
$420.44M
+1,332,059%
Hanley David C.
CHIEF TECHNICAL OPERATIONS
—
$1.43M (1) scheduled
−$1.43M
24,000
$170.22K
0.0%
Wentworth Kerry
CHIEF REGULATORY OFFICER
$89.74K (2)
$1.47M (3) scheduled
−$1.38M
53,000
$375.90K
+1,667%
Markel Stacy
CHIEF PEOPLE OFFICER
$17.10K (1)
$753.19K (1) scheduled
−$736.09K
32,591
$231.15K
+44.3%
Mashal Robert
Director
$505.24K (5)
—
+$505.24K
225,000
$1.60M
—
BLICKENSTAFF KIM D
Director
$500.09K (1)
—
+$500.09K
172,189
$1.22M
—
FALBERG KATHRYN E
Director
$483.84K (4)
—
+$483.84K
250,000
$1.77M
—
Sauvage Philippe
Chief Financial Officer
$13.22K (2)
$286.37K (1) scheduled
−$273.15K
54,131
$383.92K
+692.4%
Wang Junyuan Jerry
CEO, ANHEART THERAPEUTICS LTD.
—
$162.88K (1)
−$162.88K
6,112,686
$43.35M
—
Sjogren Colleen
Chief Commercial Officer
$90.35K (1)
—
+$90.35K
81,000
$574.48K
+161.3%
Bazemore Robert B
Director
$49.90K (1)
—
+$49.90K
5,000
$35.46K
—
WELCH DANIEL G
Director
—
—
—
659,947
$4.68M
—
VERNON W ANTHONY
Director
—
—
—
304,100
$2.16M
—
Makunje Moses
SEE REMARKS
—
—
—
68,137
$483.25K
+292.1%
Hasnain Faheem
Director
—
—
—
55,000
$390.08K
—
Sharp Shalini
Director
—
—
—
35,000
$248.23K
—
COOPER GRAHAM K
Director
—
—
—
25,000
$177.31K
—
BRADBURY DANIEL
Director
—
—
—
25,000
$177.31K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

71
Insider
Date
Role
Action
Shares
Price
Amount
Hattersley Gary
19 Aug 2026
CHIEF SCIENTIFIC OFFICER
Sold after exercise
100,000
$7.09
$709.24K
Sauvage Philippe
15 Jul 2026
Chief Financial Officer
Exercised, kept
1
$1.97
$1.97
Sauvage Philippe
15 Jul 2026
Chief Financial Officer
Exercised, kept
39,999
$2.17
$86.80K
Sauvage Philippe
23 Jun 2026
Chief Financial Officer
Sold after exercise
47,668
$6.01
$286.37K
Wentworth Kerry
23 Jun 2026
CHIEF REGULATORY OFFICER
Sold after exercise
63,000
$6.02
$379.19K
Markel Stacy
23 Jun 2026
CHIEF PEOPLE OFFICER
Sold after exercise
125,000
$6.03
$753.19K
Mashal Robert
9 Jun 2026
Director
Buy indirect
25,000
$4.73
$118.25K
Liu Dongfang
17 Apr 2026
CHIEF MEDICAL OFFICER
Sold after exercise
50,000
$5.02
$251.00K
Wentworth Kerry
17 Apr 2026
CHIEF REGULATORY OFFICER
Sold after exercise
36,750
$5.01
$184.28K
Wentworth Kerry
6 Apr 2026
CHIEF REGULATORY OFFICER
Sold after exercise
200,000
$4.52
$903.56K
Liu Dongfang
1 Dec 2025
CHIEF MEDICAL OFFICER
Sold after exercise
150,000
$7.82
$1.17M
Liu Dongfang
26 Nov 2025
CHIEF MEDICAL OFFICER
Sold after exercise
10,000
$8.00
$80.00K
Liu Dongfang
25 Nov 2025
CHIEF MEDICAL OFFICER
Sold after exercise
10,000
$7.50
$75.00K
Liu Dongfang
20 Nov 2025
CHIEF MEDICAL OFFICER
Sold after exercise
20,000
$7.00
$140.07K
Hattersley Gary
20 Nov 2025
CHIEF SCIENTIFIC OFFICER
Sold after exercise
300,000
$7.23
$2.17M
Hattersley Gary
20 Nov 2025
CHIEF SCIENTIFIC OFFICER
Sold after exercise
69,051
$7.23
$499.03K
Liu Dongfang
19 Nov 2025
CHIEF MEDICAL OFFICER
Sold after exercise
15,000
$5.10
$76.55K
Hanley David C.
19 Nov 2025
CHIEF TECHNICAL OPERATIONS
Sold after exercise
200,000
$7.14
$1.43M
Liu Dongfang
17 Nov 2025
CHIEF MEDICAL OFFICER
Sold after exercise
15,000
$4.77
$71.48K
Hattersley Gary
27 Oct 2025
CHIEF SCIENTIFIC OFFICER
Sold after exercise
100,000
$5.02
$502.46K
Markel Stacy
18 Jun 2025
CHIEF PEOPLE OFFICER
Buy
10,000
$1.71
$17.10K
Sauvage Philippe
17 Jun 2025
Chief Financial Officer
Buy
4,000
$1.79
$7.16K
Hung David
16 Jun 2025
PRESIDENT AND CEO
Buy
500,000
$1.79
$893.50K
Wentworth Kerry
16 Jun 2025
CHIEF REGULATORY OFFICER
Buy
24,000
$1.80
$43.20K
Wentworth Kerry
16 Jun 2025
CHIEF REGULATORY OFFICER
Buy
26,000
$1.79
$46.54K
Sjogren Colleen
16 Jun 2025
Chief Commercial Officer
Buy
50,000
$1.81
$90.35K
Sauvage Philippe
16 Jun 2025
Chief Financial Officer
Buy
3,300
$1.84
$6.06K
Liu Dongfang
2 May 2025
CHIEF MEDICAL OFFICER
Sold after exercise
20,000
$2.50
$50.02K
Hung David
7 Apr 2025
PRESIDENT AND CEO
Buy
300,000
$1.63
$487.50K
Hung David
4 Apr 2025
PRESIDENT AND CEO
Buy
200,000
$1.66
$332.72K
Mashal Robert
1 Apr 2025
Director
Buy indirect
98,900
$1.67
$165.15K
Mashal Robert
1 Apr 2025
Director
Buy indirect
1,100
$1.67
$1.83K
Wang Junyuan Jerry
11 Nov 2024
CEO, ANHEART THERAPEUTICS LTD.
Sell
56,361
$2.89
$162.88K
Mashal Robert
8 Oct 2024
Director
Buy indirect
99,981
$2.20
$219.96K
Mashal Robert
8 Oct 2024
Director
Buy indirect
19
$2.20
$41.71
Cui Xiangmin
25 Jun 2024
Director
Buy indirect
277,895
$2.97
$825.35K
Cui Xiangmin
24 Jun 2024
Director
Buy indirect
336,874
$2.98
$1.00M
Cui Xiangmin
21 Jun 2024
Director
Buy indirect
75,411
$3.00
$226.23K
Cui Xiangmin
20 Jun 2024
Director
Buy indirect
87,715
$2.99
$262.27K
BLICKENSTAFF KIM D
11 Jun 2024
Director
Buy indirect
172,189
$2.90
$500.09K
WELCH DANIEL G
24 May 2024
Director
Exercised, kept
366,744
$1.64
$601.46K
WELCH DANIEL G
24 May 2024
Director
Exercised, kept
293,203
$1.74
$510.17K
NODELMAN OLEG
21 Feb 2023
Director
Buy indirect
53,000
$1.36
$72.14K
NODELMAN OLEG
20 Feb 2023
Director
Buy indirect
117,100
$1.36
$159.49K
NODELMAN OLEG
19 Feb 2023
Director
Buy indirect
5,143,000
$1.26
$6.46M
FALBERG KATHRYN E
5 Dec 2022
Director
Buy indirect
43,000
$1.95
$83.96K
FALBERG KATHRYN E
2 Dec 2022
Director
Buy indirect
47,000
$1.98
$93.19K
FALBERG KATHRYN E
1 Dec 2022
Director
Buy indirect
84,959
$1.97
$167.60K
FALBERG KATHRYN E
30 Nov 2022
Director
Buy indirect
75,041
$1.85
$139.09K
Omega Fund V, L.P.
5 Apr 2022
10% owner
Sell
2,500,000
$5.60
$14.00M
Omega Fund V, L.P.
15 Dec 2021
10% owner
Sell
500,000
$10.07
$5.04M
Omega Fund V, L.P.
7 Dec 2021
10% owner
Sell
1,400,000
$9.80
$13.72M
NODELMAN OLEG
24 Nov 2021
Director
Buy indirect
21,758
$7.69
$167.23K
NODELMAN OLEG
24 Nov 2021
Director
Buy indirect
163,268
$7.69
$1.25M
Omega Fund V, L.P.
23 Nov 2021
10% owner
Sell
36
$9.75
$351.00
Omega Fund V, L.P.
22 Nov 2021
10% owner
Sell
295,000
$9.76
$2.88M
Omega Fund V, L.P.
3 Nov 2021
10% owner
Sell
2,000,000
$9.25
$18.50M
Omega Fund V, L.P.
29 Oct 2021
10% owner
Sell
45,000
$9.27
$417.15K
Omega Fund V, L.P.
28 Oct 2021
10% owner
Sell
1,015,000
$9.60
$9.74M
NODELMAN OLEG
31 Jul 2021
Director
Sell indirect
56,598
$8.64
$489.01K
NODELMAN OLEG
31 Jul 2021
Director
Buy indirect
56,598
$8.64
$489.01K
NODELMAN OLEG
13 Apr 2021
Director
Buy indirect
3,966
$10.27
$40.73K
NODELMAN OLEG
13 Apr 2021
Director
Buy indirect
27,534
$10.27
$282.80K
NODELMAN OLEG
12 Apr 2021
Director
Buy indirect
16,745
$9.49
$158.87K
NODELMAN OLEG
12 Apr 2021
Director
Buy indirect
116,255
$9.49
$1.10M
NODELMAN OLEG
9 Apr 2021
Director
Buy indirect
37,770
$10.03
$378.86K
NODELMAN OLEG
9 Apr 2021
Director
Buy indirect
262,230
$10.03
$2.63M
NODELMAN OLEG
31 Mar 2021
Director
Sell indirect
151,544
$10.45
$1.58M
NODELMAN OLEG
31 Mar 2021
Director
Buy indirect
151,544
$10.45
$1.58M
Bazemore Robert B
30 Mar 2021
Director
Buy
5,000
$9.98
$49.90K
EcoR1 Panacea Holdings, LLC
6 Jul 2020
Director
Buy
390,000
$10.00
$3.90M

What was left out

Form 4 filings counted 146
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 18
Sales at will 11
Transactions with no price 0
Shares from compensation/vesting 114,572,402
Sales filed before the plan box existed 10
History held since 6 Jul 2020